The DOI matches its Crossref record; 236 of the 236 references it cites were found in a registry or an index.
Notch inhibitors for cancer treatment
Open accessAbstract
Notch signaling is an evolutionarily conserved cell signaling pathway involved in cell fate during development, stem cell renewal and differentiation in postnatal tissues. Roles for Notch in carcinogenesis, in the biology of cancer stem cells and tumor angiogenesis have been reported. These features identify Notch as a potential therapeutic target in oncology. Based on the molecular structure of Notch receptor, Notch ligands and Notch activators, a set of Notch pathway inhibitors have been developed. Most of these inhibitors had shown anti-tumor effects in preclinical studies. At the same time, the combinatorial effect of these inhibitors with current chemotherapeutical drugs still under study in different clinical trials. In this review, we describe the basics of Notch signaling and the role of Notch in normal and cancer stem cells as a logic way to develop different Notch inhibitors and their current stage of progress for cancer patient’s treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–236 of 236
Pallavi, S. K., Ho, D. M., Hicks, C., Miele, L., & Artavanis‐Tsakonas, S. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.129 · Cited by 83
Self-citationKatoh (2009) · International Journal of Oncology · doi:10.3892/ijo_00000328 · Cited by 81
Notch3 and Canonical NF-κB Signaling Pathways Cooperatively Regulate Foxp3 Transcription
Barbarulo, A., Grazioli, P., Campese, A. F., Bellavia, D., Mario, G. D., Pelullo, M., Ciuffetta, A., Colantoni, S., Vacca, A., Frati, L., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002136 · Cited by 81
A Role of Receptor Notch in Ligand cis-Inhibition in Drosophila
Bécam, I., Fiúza, U.-M., Arias, A. M., & Milán, M. (2010) · Current Biology · doi:10.1016/j.cub.2010.01.058 · Cited by 80
PEA3 is overexpressed in mouse metastatic mammary adenocarcinomas.
Trimble, M. S., Xin, J.-H., Guy, C. T., Muller, W., & Hassell, J. A. (1993) · PubMed · Cited by 80
Cellular Notch responsiveness is defined by phosphoinositide 3-kinase-dependent signals
McKenzie, G. J., Ward, G. A., Stallwood, Y., Briend, E., Papadia, S., Lennard, A. C., Turner, M., CHAMPION, B. R., & Hardingham, G. E. (2006) · BMC Cell Biology · doi:10.1186/1471-2121-7-10 · Cited by 78
Tammam, J. G., Ware, C., Efferson, C. L., O’Neil, J., Rao, S. S., Qu, X., Gorenstein, J., Angagaw, M. H., Kim, H., Kenific, C. M., et al. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00389.x · Cited by 75
NOTCH-1 and NOTCH-4 are novel gene targets of PEA3 in breast cancer: novel therapeutic implications
Clementz, A. G., Rogowski, A., Pandya, K., Miele, L., & Osipo, C. (2011) · Breast Cancer Research · doi:10.1186/bcr2900 · Cited by 74
Self-citationRangasamy, V., Mishra, R., Sondarva, G. V., Das, S., Lee, T. H., Bakowska, J. C., Tzivion, G., Malter, J. S., Rana, B., Lu, K. P., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200804109 · Cited by 72
Tiyanont, K., Wales, T. E., Aste-Amézaga, M., Aster, J. C., Engen, J. R., & Blacklow, S. C. (2011) · Structure · doi:10.1016/j.str.2011.01.016 · Cited by 71
Stem Cells in Normal Development and Cancer
D'Angelo, R. C., & Wicha, M. S. (2010) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385071-3.00006-x · Cited by 70
Hyde, L. A., McHugh, N. A., Chen, J., Zhang, Q., Manfra, D. J., Nomeir, A. A., Josien, H. B., Bara, T. A., Clader, J. W., Zhang, L., et al. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.111716 · Cited by 69
Acetylation controls Notch3 stability and function in T-cell leukemia
Palermo, R., Checquolo, S., Giovenco, A., Grazioli, P., Kumar, V., Campese, A. F., Giorgi, A., Napolitano, M., Canettieri, G., Ferrara, G., et al. (2011) · Oncogene · doi:10.1038/onc.2011.533 · Cited by 67
Crosstalk between NOTCH and AKT signaling during murine megakaryocyte lineage specification
Cornejo, M., Mabialah, V., Sykes, S. M., Khandan, T., Celso, C. L., Lopez, C. K., Rivera-Muñoz, P., Rameau, P., Tóthová, Z., Aster, J. C., et al. (2011) · Blood · doi:10.1182/blood-2011-01-328567 · Cited by 65
Hayashi, I., Takatori, S., Urano, Y., Miyake, Y., Takagi, J., Sakata‐Yanagimoto, M., Iwanari, H., Osawa, S., Morohashi, Y., Li, T., et al. (2011) · Oncogene · doi:10.1038/onc.2011.265 · Cited by 65
RING1 inhibits transactivation of RBP-J by Notch through interaction with LIM protein KyoT2
Qin, H. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh295 · Cited by 64
Pinchot, S. N., Jaskula‐Sztul, R., Li, N., Peters, N. R., Cook, M. R., Kunnimalaiyaan, M., & Chen, H. (2010) · Cancer · doi:10.1002/cncr.25652 · Cited by 61
Current views on the role of Notch signaling and the pathogenesis of human leukemia
Pancewicz, J., & Nicot, C. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-502 · Cited by 60
Notch-related genes in animal development
Lardelli, M., Williams, R. T. P., & Lendahl, U. (1995) · The International Journal of Developmental Biology · doi:10.1387/ijdb.8645561 · Cited by 57
Zhang, X. (2011) · Oncology Reports · doi:10.3892/or.2011.1380 · Cited by 56
Raimondi, L., Ciarapica, R., Salvo, M. D., Verginelli, F., Guéguen, M., Martini, C., Sio, L. D., Cortese, B., Locatelli, M., Dang, T. P., et al. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.171 · Cited by 55
Self-citationThe intracellular region of Notch ligands: does the tail make the difference?
Pintar, A., Biasio, A. D., Popovic, M., Ivanova, N., & Pongor, S. (2007) · Biology Direct · doi:10.1186/1745-6150-2-19 · Cited by 55
Reciprocal regulation of Notch and PI3K/Akt signalling in T‐ALL cells In Vitro
Calzavara, E., Chiaramonte, R., Cesana, D., Basile, A., Sherbet, G. V., & Comi, P. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21527 · Cited by 53
Reynolds, N. D., Lukacs, N. W., Long, N. C., & Karpus, W. J. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100160 · Cited by 52
He, W., Luistro, L. L., Carvajal, D. M., Smith, M., Nevins, T., Yin, X., Cai, J. J., Higgins, B., Kolinsky, K. D., Rizzo, C., et al. (2011) · Molecular Oncology · doi:10.1016/j.molonc.2011.01.001 · Cited by 51
Ubiquitination of Notch1 is regulated by MAML1-mediated p300 acetylation of Notch1
Popko-Ścibor, A. E., Lindberg, M. J., Hansson, M. L., Holmlund, T., & Wallberg, A. E. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.11.030 · Cited by 44
Notch signaling in pediatric malignancies
Zweidler‐McKay, P. A. (2008) · Current Oncology Reports · doi:10.1007/s11912-008-0071-2 · Cited by 38
Phosphorylation of Ser2078 Modulates the Notch2 Function in 32D Cell Differentiation
Inglés‐Esteve, J., Espinosa, L., Milner, L. A., Caelles, C., & Bigas, A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104703200 · Cited by 38
Guo, D., Teng, Q., & Ji, C. (2011) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2011.564696 · Cited by 34
Imbalanced expression of TAN-1 and human Notch4 in endometrial cancers.
Suzuki, T., Aoki, D., Susumu, N., Udagawa, Y., & Nozawa, S. (2000) · International Journal of Oncology · doi:10.3892/ijo.17.6.1131 · Cited by 32
Choi, J. W., Pampeno, C. L., Vukmanović, S., & Meruelo, D. (2002) · Developmental & Comparative Immunology · doi:10.1016/s0145-305x(01)00095-7 · Cited by 30
Fan, L., Liu, Y., Ying, H., Xue, Y., Zhang, Z., Wang, P., Liu, L., & Zhang, H. (2010) · Journal of Molecular Neuroscience · doi:10.1007/s12031-010-9479-x · Cited by 30
Clinical significance of PEA3 in human breast cancer
Kinoshita, J., Kitamura, K., Tanaka, S., Sugimachi, K., Ishida, M., & Saeki, H. (2002) · Surgery · doi:10.1067/msy.2002.119792 · Cited by 24
Pediatric developmental therapies: Interesting new drugs now in early-stage clinical trials
Macy, M. E., Sawczyn, K. K., Garrington, T. P., Graham, D. K., & Gore, L. (2008) · Current Oncology Reports · doi:10.1007/s11912-008-0073-0 · Cited by 19
Albain, K. S., Czerlanis, C. M., Zlobin, A., Covington, K., Rajan, P., Godellas, C. V., Bova, D., Lo, S., Robinson, P., Sarker, S., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.sabcs11-s1-5 · Cited by 18
Self-citationHajdú, M., Kopper, L., & Sebestyén, A. (2009) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2009.02346.x · Cited by 11
Cited by
Targeting cancer stem cell pathways for cancer therapy
Yang, L., Shi, P., Zhao, G., Xu, J., Peng, W., Zhang, J., Zhang, G., Wang, X., Dong, Z., Chen, F., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0110-5 · Cited by 1,906
Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update
Takebe, N., Miele, L., Harris, P. J., Jeong, W., Bando, H., Kahn, M., Yang, S. X., & Ivy, S. P. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.61 · Cited by 1,298
Self-citationPancancer survival analysis of cancer hallmark genes
Nagy, Á., Munkácsy, G., & Győrffy, B. (2021) · Scientific Reports · doi:10.1038/s41598-021-84787-5 · Cited by 1,381
Saunders, L. R., Bankovich, A. J., Anderson, W. C., Aujay, M. A., Bheddah, S., Black, K., Desai, R., Escarpe, P. A., Hampl, J., Laysang, A., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aac9459 · Cited by 600
Chen, X., Tang, J., Shuai, W., Meng, J., Feng, J., & Han, Z. (2020) · Inflammation Research · doi:10.1007/s00011-020-01378-2 · Cited by 423
Metadata
- Authors
- Espinoza, I., & Miele, L.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2013-08
- Volume
- 139
- Issue
- 2
- Pages
- 95-110
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W1970820847
- Cited by
- 273
- References
- 236
- FWCI
- 12.37
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.